PlexusDx's $99 genetic test maps 14 pathways and identifies key variants in GLP1R, FTO, MC4R, and GIPR that influence appetite sensitivity and weight-regain likelihood
Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in greater weight loss and better glucose lowering than medications that target GLP-1 alone, said Isaacs
Bosy-Westphal A, Muller MJ (2021) Diagnosis of obesity based on body composition-associated health risks-time for a change in paradigm
Yes, doses above 3 mg daily provide minimal additional libido benefits while significantly increasing side effects including severe nausea, hyperpigmentation, and potential cardiovascular stress
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agent
They work by adjusting the levels of certain chemicals in the brain, aiming to lift mood and reduce feelings of sadness or hopelessness